1. Home
  2. QTRX vs HUMA Comparison

QTRX vs HUMA Comparison

Compare QTRX & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanterix Corporation

QTRX

Quanterix Corporation

SELL

Current Price

$3.14

Market Cap

160.0M

Sector

Industrials

ML Signal

SELL

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$0.36

Market Cap

165.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QTRX
HUMA
Founded
2007
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.0M
165.7M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
QTRX
HUMA
Price
$3.14
$0.36
Analyst Decision
Hold
Buy
Analyst Count
3
6
Target Price
★ $3.17
$1.63
AVG Volume (30 Days)
633.6K
★ 4.8M
Earning Date
11-09-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 79.37
EPS
N/A
★ N/A
Revenue
★ $37,632,000.00
$2,038,000.00
Revenue This Year
$3.21
$72.32
Revenue Next Year
$9.96
$518.79
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 64.52
N/A
52 Week Low
$2.15
$0.36
52 Week High
$8.77
$1.90

Technical Indicators

Market Signals
Indicator
QTRX
HUMA
Relative Strength Index (RSI) 47.57 19.62
Support Level $2.89 N/A
Resistance Level $3.88 $0.75
Average True Range (ATR) 0.26 0.03
MACD -0.05 -0.01
Stochastic Oscillator 8.02 10.50

Price Performance

Historical Comparison
QTRX
HUMA

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: